On-demandOn-demand

Sponsored Webcast: Risk Assessment in the Life Sciences (On Demand)

1.0 RAC Credits Member: $0 | Nonmember: $50
Sponsored Webcast: Risk Assessment in the Life Sciences (On Demand)

Are you in a good state for the next tech advancement?

Ensuring the quality and safety of products is one of the most critical aspects of life sciences companies, from pharmaceuticals to biotechnology and medical devices. This includes categorizing and appropriately reviewing and monitoring processes, systems, facilities, and equipment. If you’re not doing this consistently and correctly, you’re not ready for artificial intelligence (AI) or other technology advancements.

In this webcast, panelists will discuss risk assessment approaches that enable companies to be more efficient, and therefore keep up with technology and bring on new systems (which will have more maintenance). They also will discuss upstream and downstream impacts of risk assessment. Panelists will share their experiences, including lessons learned, best practices, and the future of risk assessment.

Registration Fees & Deadlines

Member $0 | Non-Member $50

Learning Objectives

  • Risk management approaches and best practices
  • Future possibilities of tech-enabled risk management
  • Case studies and lessons learned

Who Should Attend?

Life science leaders who oversee compliance, quality, regulatory, IT, GxP Systems.

Audience Learning Level

Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.

Speakers

Leslie Cort

Staci Spencer
Director, Quality, Sware 

Stephanie Seidel

Blake Jensen SVP
Quality Assurance, HUYABIO International

Quality and compliance executive with over 20 years of experience working in emerging pharma/biotech and contract service providers, as well as being a former inspector for the US FDA. Blake has served as head of quality for multiple biopharmaceutical companies, including several where he was the first person hired in a quality role and built the company’s quality systems from scratch. He has experience working across the GXP spectrum and has conducted audits in all regions of the world.